APLN and neoplasm: To study the contribution to tumor growth of Apelin from cancer cells or cells of the tumor microenvironment, we used the E0771 mammary cancer model and, first, specifically downregulated the expression of Apln in cancer cells using shRNA (Fig EV2B).